The German Competence Network on Atrial Fibrillation (AFNET).

Herz
Günter BreithardtStephan Willems

Abstract

The German Competence Network on Atrial Fibrillation (AFNET) is an interdisciplinary national research network funded by the Federal Ministry of Education and Research (BMBF) since 2003. The AFNET aims at improving treatment of atrial fibrillation (AF), the most frequent sustained arrhythmia of the heart. The AFNET has established a nationwide patient registry on manifestation, diagnostics, and therapy of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple comorbidities (hypertension, valvular heart disease, coronary artery disease, diabetes mellitus) and an advanced age. Regarding oral anticoagulation, guideline adherence is very high. Basic research has identified specific changes in atrial tissue during AF-induced remodeling providing the rationale for novel therapeutic interventions. Clinical trials are being carried out to optimize pharmacological and nonpharmacological treatments. The ANTIPAF trial is designed to prove that angiotensin II receptor blockers reduce the incidence of paroxysmal AF. The Flec-SL trial tests the efficacy of a short-term treatment with antiarrhythmic drugs after cardioversion. The Gap-AF trial investigates the impact of complete pulmonary vein (P...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Apr 30, 2002·American Journal of Epidemiology·Wendy A WattigneyJanet B Croft
Aug 28, 2003·JAMA : the Journal of the American Medical Association·Thomas J WangEmelia J Benjamin
Oct 3, 2003·Journal of Cardiovascular Electrophysiology·Paulus KirchhofWilhelm Haverkamp
Aug 11, 2004·European Heart Journal·Thomas FetschUNKNOWN Prevention of Atrial Fibrillation after Cardioversion Investigators
Oct 6, 2005·European Heart Journal·Robby NieuwlaatUNKNOWN European Heart Survey Investigators
Aug 9, 2006·Circulation·Ali El-ArmoucheDobromir Dobrev
Sep 7, 2007·Clinical Drug Investigation·Andreas GoetteThomas Meinertz
Sep 28, 2007·European Heart Journal·Paulus KirchhofGünter Breithardt
Sep 28, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Paulus KirchhofGünter Breithardt
Oct 2, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Emanuele BertagliaGiuseppe Stabile
Nov 20, 2008·Journal of Cardiovascular Electrophysiology·Stephan ZellerhoffPaulus Kirchhof

❮ Previous
Next ❯

Citations

Jul 14, 2011·QJM : Monthly Journal of the Association of Physicians·F D Richard Hobbs, I Leach
Jan 13, 2009·Herz·Erik WissnerKarl-Heinz Kuck
Mar 17, 2016·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Paulus KirchhofUlrich Schotten
Jun 28, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN Writing Committee of the Action for Stroke Prevention alliance
Oct 14, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Sercan OkutucuAndreas Goette

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Journal of Psychosomatic Research
Helmut W Lange, Christoph Herrmann-Lingen
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Paulus KirchhofGünter Breithardt
Patient Education and Counseling
Gregory Makoul, Marla L Clayman
© 2021 Meta ULC. All rights reserved